AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Lumos Diagnostics Holdings Limited
Video analysis: LDX.AX
All videosNo video analysis for this stock yet. Request one from our team.
News: LDX.AX
Nvidia Q2 earnings beat expectations with strong data center growth
Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) forecast third-quarter revenue above Wall Street estimates on Wednesday, extending a run of blowout results driven by...
FTSE 100 Live: Next and Glencore provide results boost, SpaceX tumbles
FTSE 100 up 19 points to 10,899 Oil prices waver as Hormuz deal mooted SpaceX's earnings beat runs into a $116bn problem Next, Glencore, Legal & General,...
Tower Semiconductor tops second quarter earnings and revenue expectations
Tower Semiconductor (NASDAQ:TSEM) has reported second quarter results above Wall Street expectations, including record revenue and profitability as the...
Lumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a US$767,800 purchase order for its FebriDx® rapid diagnostic test from US distribution...
Small Cap watch: Pantoro hits spectacular gold and Lumos secures US order
The S&P/ASX Small Ordinaries continued its positive run, rising 26.6 points, or 0.8%, to close yesterday at 3,341.2. The small-cap benchmark has now gained...
Starbucks Q3 profit beats on US turnaround, lifts full-year guidance
Starbucks Corp (NASDAQ:SBUX, XETRA:SRB) beat Wall Street estimates for fiscal third-quarter revenue and profit as its turnaround plan drove...
Shell plans £3.1bn of buybacks as profits soar on higher oil prices
Shell PLC (LSE:SHEL, NYSE:SHEL) shares rose after stronger oil and gas prices and improved trading led to its highest profits since 2022, with $4.2 billion...
Cameco gets UBS upgrade on strengthening uranium bull case
Cameco Corporation (TSX:CCO) has been upgraded to Buy by UBS on a strengthened uranium bull case that analysts believe is not reflected in the producer's...
Similar companies
-
Pacific Edge Limited
PEB.AX
·
Australian Securities Exchange
Compare
-
Tetratherix Ltd.
TTX.AX
·
Australian Securities Exchange
Compare
-
SomnoMed Limited
SOM.AX
·
Australian Securities Exchange
Compare
-
EMVision Medical Devices Ltd
EMV.AX
·
Australian Securities Exchange
Compare
-
AVITA Medical, Inc.
AVH.AX
·
Australian Securities Exchange
Compare
-
Paradigm Biopharmaceuticals Limited
PAR.AX
·
Australian Securities Exchange
Compare